Relationship between saliva and plasma rufinamide concentrations in patients with epilepsy-Reference-Cited by-同舟云学术

Relationship between saliva and plasma rufinamide concentrations in patients with epilepsy

Published:2020-06-20 Issue:7 Volume:61 Page:
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Franco Valentina¹²^ORCID,Gatti Giuliana¹,Mazzucchelli Iolanda¹,Marchiselli Roberto¹,Fattore Cinzia²,Rota Paola³,Galimberti Carlo Andrea²,Capovilla Giuseppe⁴⁵,Beccaria Francesca⁴,De Giorgis Valentina²,Johannessen Landmark Cecilie⁶⁷^ORCID,Perucca Emilio¹²^ORCID

Affiliation:

1. Division of Clinical and Experimental Pharmacology Department of Internal Medicine and Therapeutics University of Pavia Pavia Italy

2. IRCCS Mondino Foundation Pavia Italy

3. Department of Biomedical, Surgical, and Dental Sciences University of Milan Milan Italy

4. Epilepsy Center C. Poma Hospital Mantua Italy

5. Fondazione Poliambulanza Brescia Italy

6. Program for Pharmacy Faculty of Health Sciences Oslo Metropolitan University Oslo Norway

7. Section for Clinical Pharmacology Department of Pharmacology National Center for Epilepsy Oslo University Hospital Oslo Norway

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.16584

Reference14 articles.

1. Banzel (rufinamide). Full prescribing information.Woodcliff Lake NJ:Eisai.Last revised February 2015. Available at:https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021911s012lbl.pdf. Accessed April 16 2020.

2. Inovelon (rufinamide). Summary of product characteristics.Hatfield UK:Eisai. Last revised July 2019. Available at:https://www.medicines.org.uk/emc/product/410/smpc.Accessed April 16 2020.

3. Rufinamide: Clinical pharmacokinetics and concentrationresponse relationships in patients with epilepsy

4. Antiepileptic drugsbest practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies

5. Therapeutic Drug Monitoring of Antiepileptic Drugs by Use of Saliva

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring levetiracetam concentration in saliva during pregnancy is stable and feasible;CNS Neuroscience & Therapeutics;2024-07

2. Research Status, Synthesis and Clinical Application of Antiepileptic Drugs;Current Medicinal Chemistry;2024-02

3. Huanglian Jiedu Wan intervened with “Shi-Re Shanghuo” syndrome through regulating immune balance mediated by biomarker succinate;Clinical Immunology;2024-01

4. Therapeutic Salivary Monitoring of Perampanel in Patients with Epilepsy Using a Volumetric Absorptive Microsampling Technique;Pharmaceutics;2023-07-27

5. Salivary Biomarkers of Anti-Epileptic Drugs: A Narrative Review;Diagnostics;2023-06-04